Asia-Pacific Insulin Infusion Pumps Market Trends

Statistics for the 2023 & 2024 Asia-Pacific Insulin Infusion Pumps market trends, created by Mordor Intelligence™ Industry Reports. Asia-Pacific Insulin Infusion Pumps trend report includes a market forecast to 2029 and historical overview. Get a sample of this industry trends analysis as a free report PDF download.

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Single User License

$4750

Team License

$5250

Corporate License

$8750

Book before:

Market Trends of Asia-Pacific Insulin Infusion Pumps Industry

Insulin Infusion Pump Devices Dominating the Asia-Pacific Insulin Infusion Pump Market

An insulin pump is a device that delivers insulin continuously or, whenever required, automatically. The pump mimics the human pancreas. The insulin is provided by a tube (catheter), which is attached to a thin cannula, which is inserted into the layer of fat beneath your skin, usually in the area around your stomach, by the pump, which is approximately the size of a smartphone or deck of cards and worn on the exterior of your body.

The pump can be carried in a pump case around your waist, strapped to a belt or bra, tucked into a pocket, or worn on an armband. You can have your insulin pump look stylish with specially manufactured attachments. The insulin infusion pump works as an alternative to the traditional system of daily injections or an insulin pen. An autoimmune reaction in which the body's immune system attacks the insulin-producing beta cells in the pancreas is the primary cause of type-1 diabetes. 

To maintain appropriate glucose levels, patients with type-1 diabetes need daily insulin injections, usually up to four times a day. Chronic glucose levels may lead to complications such as retinopathy and nephropathy.

Insulin pump therapy is a treatment in which insulin is continuously administered using a portable pump. The insulin is delivered into the patient's body through a subcutaneously inserted cannula. Because the insulin dosage can be adjusted accurately depending on day-to-day activities such as exercise and meal choice, it is expected to improve glucose management and help prevent complications.

An insulin pump has been demonstrated in studies to enhance diabetes management and reduce the risk of hypoglycemia. When using an insulin pump, many patients find that they have more freedom in timing their meals and activities. Sharing insulin pump data with the care team between office visits allows patients to get the most out of the time they spend with them during their sessions.

Uploading pump data helps the care team track patterns and, if necessary, make changes to your care plan. Insulin pumps use short-acting and rapid-acting insulin but are not long-acting since the pump is programmed to deliver a small amount continuously to keep your blood sugar levels even. Most insurance companies cover insulin pumps.

Asia-Pacific Insulin Infusion Pump market, Volume CAGR (in %), by component, 2023-2028

Australia and China are Expected to Dominate the Asia-Pacific Insulin Infusion Pump Market.

Among the Asia-Pacific countries, Australia and China dominate around 56% of the total Asia-Pacific insulin infusion pump market. This is mainly due to the high prevalence of diabetes in these countries. China records the highest healthcare expenditure in the Asia-Pacific region. 

Without private health insurance, insulin pumps can cost between USD 5,000 and USD 10,000 or more. Several private health insurance providers subsidize the price of an insulin pump. Insulin pump consumables such as pump sets and lines are an ongoing cost for the patient and are not usually covered by private health insurance, NDSS, or Medicare. Although the pump and its supplies (tubing, insulin cartridges, and infusion sets) remain expensive, insurance coverage has improved considerably.

Moreover, governments and healthcare organizations in the Asia-Pacific region are increasingly focusing on diabetes management and prevention programs. This includes initiatives to raise awareness about diabetes, promote early diagnosis, and provide access to affordable treatment options. As a part of these efforts, insulin infusion pumps are being recommended as an effective tool for diabetes management, further driving the market growth.

In conclusion, the rising prevalence of diabetes in the Asia-Pacific region, coupled with the advantages offered by insulin infusion pumps and supportive healthcare initiatives, is significantly contributing to the growth of the insulin infusion pump market in this region.

Therefore, owing to the factors above, the growth of the studied market is anticipated in the Asia-Pacific region.

Asia-Pacific Insulin Infusion Pump Market, Diabetes Population in million, by Country, 2017-2022

Asia-Pacific Insulin Infusion Pump Market Size & Share Analysis - Growth Trends & Forecasts (2024 - 2029)